854 related articles for article (PubMed ID: 26132932)
1. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
2. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
González F
Steroids; 2012 Mar; 77(4):300-5. PubMed ID: 22178787
[TBL] [Abstract][Full Text] [Related]
3. Inflammation Triggered by Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
González F; Considine RV; Abdelhadi OA; Acton AJ
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2152-67. PubMed ID: 32140727
[TBL] [Abstract][Full Text] [Related]
4. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
[TBL] [Abstract][Full Text] [Related]
5. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.
Dumesic DA; Tulberg A; Leung KL; Fisch SC; Grogan TR; Abbott DH; Naik R; Chazenbalk GD
Fertil Steril; 2021 Jul; 116(1):232-242. PubMed ID: 33341231
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
[TBL] [Abstract][Full Text] [Related]
7. The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.
Luque-Ramírez M; Alpañés M; Escobar-Morreale HF
Fertil Steril; 2010 Nov; 94(6):2214-21. PubMed ID: 20097337
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
[TBL] [Abstract][Full Text] [Related]
9. Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome.
González F; Considine RV; Abdelhadi OA; Xue J; Acton AJ
Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E689-E701. PubMed ID: 34632798
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
[TBL] [Abstract][Full Text] [Related]
11. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
13. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
[TBL] [Abstract][Full Text] [Related]
14. Abdominal adiposity and the polycystic ovary syndrome.
Escobar-Morreale HF; San Millán JL
Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
[TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
16. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society.
Yildiz BO; Azziz R;
Fertil Steril; 2010 Jul; 94(2):690-3. PubMed ID: 19394000
[TBL] [Abstract][Full Text] [Related]
17. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
[TBL] [Abstract][Full Text] [Related]
18. Oxidative Stress in Response to Saturated Fat Ingestion Is Linked to Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome.
González F; Considine RV; Abdelhadi OA; Acton AJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5360-5371. PubMed ID: 31298704
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.
González F; Rote NS; Minium J; Kirwan JP
J Clin Endocrinol Metab; 2006 Jan; 91(1):336-40. PubMed ID: 16249279
[TBL] [Abstract][Full Text] [Related]
20. Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.
González F; Considine RV; Abdelhadi OA; Acton AJ
Hum Reprod; 2020 May; 35(5):1168-1177. PubMed ID: 32325487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
